Evidence map›Paper›PMID 8892860›Full record

ArticleJournal of virology1996

The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells.

D P Frazier, D Cox, E M Godshalk, P A Schaffer

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D P FrazierDivision of Molecular Genetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
D Cox
E M Godshalk
P A Schaffer
Dana-Farber Cancer Institute · US

Funding

REGUL. OF GENE EXPRESSION IN PROKARYOTES AND EUKARYOTEST32GM007196 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WINSTON, FRED M. · 1985 to 2005
$2.8M
MECHANISM OF LATENCY OF HERPES SIMPLEX VIRUSP01AI024010 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SCHAFFER, PRISCILLA A · 1987 to 1995
–
IMMEDIATE-EARLY GENES OF HSVR37CA020260 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHAFFER, PRISCILLA A · 1990 to 1997
–
NCI NIH HHS R37CA20260NIAID NIH HHS P01AI24010NIGMS NIH HHS T32GM07196
6 · The paper itself

Abstract

Herpes simplex virus establishes latent infections in the nuclei of sensory neurons. These infections are characterized by the abundant expression of a series of 5' coterminal transcripts termed the latency-associated transcripts (LATs). Available evidence indicates that LAT expression is specifically regulated in latently infected neurons. Although previous studies have examined the regulation of LAT expression in neuronal and nonneuronal cells, the mechanism of regulation of LAT expression in neuronal cells in response to external factors has not been investigated. To address this question, we characterized the activity of LAT promoter fusion constructs in PC12 cells following treatment with nerve growth factor (NGF) and/or sodium butyrate (NaB), agents that affect expression of cell cycle-associated genes. Expression from the LAT promoter was induced 8- to 12-fold by either NGF or NaB alone and 40- to 60-fold when the two agents were added simultaneously. Fibroblast growth factor also induced expression from the LAT promoter but to a lesser extent than NGF. Treatment with factors such as epidermal growth factor, phorbol myristate acetate, cyclic AMP, or KCI had no significant effect on LAT promoter activity. Notably, promoter-reporter constructs containing immediate-early (ICP0 and ICP4), early (ICP8 and UL9), and late (UL10 and UL30) viral promoters were induced only two- to fourfold by NGF, suggesting that the LAT promoter may be unusual among herpes simplex virus genes in the magnitude of its response to this factor. To identify pathways leading to LAT activation in vitro, we characterized the response of the LAT promoter to NGF and/or NaB in PC12-derived cell lines containing mutations in specific signal transduction pathways. We found that activation of the LAT promoter requires Ras activation and that activation of the serine/threonine kinase, Raf, is sufficient to induce LAT expression. Together, these results indicate that the LAT promoter is regulated via the Ras/Raf signal transduction pathway in response to external factors such as NGF and NaB and that LAT expression may be regulated by NGF in latently infected neurons.

Indexed as

Promoter Regions, GeneticAnimalsButyratesButyric AcidFibroblast Growth FactorsGene Expression Regulation, ViralHerpesvirus 1, HumanHumansNerve Growth FactorsPC12 CellsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-rafras ProteinsRatsVirus LatencyButyratesButyric AcidFibroblast Growth FactorsNerve Growth FactorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-rafras Proteins

Identifiers

PMID8892860
PMCPMC190809
OpenAlexW2134464982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.